EVIDENCE TYPE
Feeding trials
Randomized trials gave people this food, or a concentrated form of it, and measured the change.
NUTRIENT DENSITY
Not part of the published powerhouse score, or below its cutoff. That score counts vitamins and minerals, not plant compounds.
Why it earns a place
Garlic is proof that a nutrient score is not the whole story. It fell short of the powerhouse cutoff, which counts vitamins and minerals, yet it has more randomized trials behind it than most vegetables on this list.
What the research shows
- 1
An updated meta-analysis of 20 randomized trials (970 participants) found garlic preparations lowered systolic blood pressure by 5.1 mmHg on average and by 8.7 mmHg in people with hypertension.
Ried K. The Journal of nutrition, 2016. PMID 26764326 · DOI
- 2
A meta-analysis of 12 case-control studies linked high garlic intake with 40% lower gastric cancer risk (RR 0.60).
Turati F, Pelucchi C, Guercio V, La Vecchia C, et al. Molecular nutrition & food research, 2015. PMID 25215621 · DOI
- 3
Garlic was one of six foods, with onion, blueberry, raspberry, cranberry and tangerine, that did not meet the 17-nutrient powerhouse criterion.
Di Noia J. Preventing chronic disease, 2014. PMID 24901795 · DOI
What it doesn’t show
The blood-pressure trials tested garlic supplements and preparations, not cloves in your cooking.
Ried K. The Journal of nutrition, 2016. PMID 26764326 · DOI
The gastric-cancer evidence comes mainly from case-control studies; four cohort studies of allium vegetables found no association (RR 1.02).
Turati F, Pelucchi C, Guercio V, La Vecchia C, et al. Molecular nutrition & food research, 2015. PMID 25215621 · DOI
FROM THE STUDY LIBRARY
More studies on garlic
29 peer-reviewed studies, each summarized from its published abstract. Strongest study types first.
2019 / Systematic review and meta-analysis
In patients with diabetes, garlic intake significantly improved lipid parameters, fasting blood sugar, and HbA1C compared to placebo.
A systematic review and meta-analysis of 33 studies evaluated the effects of garlic compared with placebo in 1,273 individuals with diabetes. Garlic was associated with significant decreases in total cholesterol by 16.87 mg/dl (95% CI, -21.01 to -12.73; P=0.001), LDL by 9.65 mg/dl (95% CI, -15.07 to -4.23; P=0.001), triglycerides by 12.44 mg/dl (95% CI, -18.19 to -6.69; P=0.001), fasting blood sugar by 10.90 mg/dl (95% CI, -16.40 to -5.40; P=0.001), and HbA1C by 0.60 mg/dl (95% CI, -0.98 to -0.22; P=0.001). Serum HDL significantly increased by 3.19 mg/dl (95% CI, 1.85 to 4.53; P=0.001).
Shabani E, Sayemiri K, Mohammadpour M Prim Care Diabetes, 2019. PMID 30049636
2019 / Systematic review and meta-analysis of randomized controlled trials
Garlic supplementation significantly reduced serum C-reactive protein levels in a meta-analysis of randomized controlled trials.
A systematic review and meta-analysis of nine randomized controlled trials with a total sample size of 363 evaluated the effects of garlic supplementation on serum C-reactive protein (CRP) levels. Compared with controls, garlic intake significantly reduced serum CRP concentrations by 0.8 mg/L (95% CI [-1.5, -0.1], p = 0.02), with evidence of heterogeneity among studies. Subgroup analyses showed significant reductions of 0.82 mg/L (95% CI [-1.02, -0.62], p < 0.001) in trials with doses ≥1,200 mg/day and 2.44 mg/L (95% CI [-4.02, -0.87], p = 0.002) in trials with baseline CRP ≥2 mg/L.
Taghizadeh M, Hamedifard Z, Jafarnejad S Phytother Res, 2019. PMID 30370629
2019 / Meta-analysis of randomized controlled trials
Garlic supplementation reduced circulating inflammatory markers CRP, IL-6, and TNF in adults.
A meta-analysis of 16 randomized controlled trials evaluated garlic doses between 12 and 3,600 mg daily for 2 to 52 weeks. Garlic administration lowered serum C-reactive protein (WMD -0.61 mg/L, 95% CI -1.12 to -0.11), IL-6 (WMD -0.73 ng/L, 95% CI -1.06 to -0.40), and TNF (WMD -0.26 ng/L, 95% CI -0.41 to -0.12). Conversely, garlic exerted no significant effect on adiponectin or leptin levels.
Darooghegi Mofrad M, Milajerdi A, Koohdani F, et al. J Nutr, 2019. PMID 30949665
2018 / Systematic review
Evidence for superfood effects on metabolic syndrome risk factors remains limited
A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.
van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436
Educational content, not medical advice. These studies describe associations or short-term risk markers; they do not show that any single food treats or prevents disease.